Expression of serine proteases and metalloproteinases in human pituitary adenomas and anterior pituitary lobe tissue
- PMID: 12904990
- DOI: 10.1007/s00401-003-0747-5
Expression of serine proteases and metalloproteinases in human pituitary adenomas and anterior pituitary lobe tissue
Abstract
Data on the dural invasiveness of pituitary adenomas have been correlated to the expression of matrix metalloproteinases (e.g. MMP-9). Serine proteases have not yet been investigated in human pituitary adenomas. In this study, paraffin-embedded material from 84 human pituitary adenomas (acromegaly n=18, Cushing's disease n=21, prolactinoma n=18, thyroid-stimulating hormone-secreting adenoma n=1, nonsecreting adenoma n=26) and 9 nontumourous anterior pituitary lobes (obtained from patients with prostate cancer) was immunohistochemically analysed for expression of MMP-2, MMP-9, tissue inhibitor of metalloproteinases-2 (TIMP-2), urokinase-type plasminogen activator (uPA), uPA receptor (uPAR), tissue-type plasminogen activator (tPA), plasminogen activator inhibitor-1 (PAI-1), and interleukin-6 (IL-6). Cavernous sinus invasion was determined by assessment of preoperative magnetic resonance imaging and intraoperative inspection (invasive n=50, noninvasive n=34). In pituitary adenomas, reactions were positive (diffuse expression) to MMP-2 (74% of cases), MMP-9 (49%), TIMP-2 (88%), uPA (89%), uPAR (90%), tPA (69%), and PAI-1 (87%). A weak expression of IL-6 was found in 12% of the adenomas. All reactions were positive (focal expression) in every sample of anterior lobe tissue, except for uPA (negative in 3 out of 9 cases), and IL-6 (faintly positive in 5 out of 8 cases). Adenomas showed remarkably greater expression of uPA than anterior lobe tissue (Chi-square P<0.05). Nonsecreting adenomas exhibited a stronger tendency towards overexpression of uPA in invasive tumours when compared to noninvasive adenomas (Chi-square P=0.053). We found no correlation of MMP-9 expression and tumour invasion. TIMP-2 was overexpressed in noninvasive as compared to invasive adenomas (Chi-square P<0.05). The interrelationship between MMPs and serine proteinases in pituitary adenomas remains to be elucidated. From our data, a correlation between IL-6 and an activation of MMP-9 cannot be proven. The uPA-system may, however, play a role in dural invasion of pituitary adenomas.
Similar articles
-
[Role of matrix metalloproteinases-9, 2 and their inhibitor-TIMP-1, 2 in invasive pituitary adenomas biological behavior].Ai Zheng. 2002 Oct;21(10):1124-8. Ai Zheng. 2002. PMID: 12508658 Chinese.
-
[Expression of MMPPs and TIMP and invasiveness in pituitary adenomas].Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2004 Dec;29(6):647-50. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2004. PMID: 16114548 Chinese.
-
Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer.BMC Cancer. 2006 Aug 18;6:211. doi: 10.1186/1471-2407-6-211. BMC Cancer. 2006. PMID: 16916471 Free PMC article.
-
The urokinase plasminogen activator system: a rich source of tumour markers for the individualised management of patients with cancer.Clin Biochem. 2004 Jul;37(7):541-8. doi: 10.1016/j.clinbiochem.2004.05.013. Clin Biochem. 2004. PMID: 15234235 Review.
-
Neutral proteinases and their inhibitors in the loosening of total hip prostheses.Acta Orthop Scand Suppl. 1996 Oct;271:3-29. Acta Orthop Scand Suppl. 1996. PMID: 8975533 Review.
Cited by
-
Does MMP-9 Gene Polymorphism Play a Role in Pituitary Adenoma Development?Dis Markers. 2017;2017:5839528. doi: 10.1155/2017/5839528. Epub 2017 Jan 17. Dis Markers. 2017. PMID: 28194042 Free PMC article.
-
Matrix metalloproteinase 2 (MMP-2) levels are increased in active acromegaly patients.Endocrine. 2017 Jul;57(1):148-155. doi: 10.1007/s12020-017-1283-8. Epub 2017 Mar 22. Endocrine. 2017. PMID: 28332074
-
Elevated cell invasion is induced by hypoxia in a human pituitary adenoma cell line.Cell Adh Migr. 2007 Jan-Mar;1(1):43-51. Epub 2007 Jan 27. Cell Adh Migr. 2007. PMID: 19262092 Free PMC article.
-
Emerging Histopathological and Genetic Parameters of Pituitary Adenomas: Clinical Impact and Recommendation for Future WHO Classification.Endocr Pathol. 2016 Jun;27(2):115-22. doi: 10.1007/s12022-016-9419-6. Endocr Pathol. 2016. PMID: 26874696 Review.
-
Expression of laminin beta2: a novel marker of hypoxia in pituitary adenomas.Endocr Pathol. 2006 Fall;17(3):251-61. doi: 10.1385/ep:17:3:251. Endocr Pathol. 2006. PMID: 17308362
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous